http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106754741-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-163 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9446 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
filingDate | 2017-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106754741-B |
titleOfInvention | Hybridoma cell strain secreting anti-1-amino-hydantoin monoclonal antibody and application thereof |
abstract | The invention discloses a hybridoma cell strain secreting an anti-1-amino-hydantoin monoclonal antibody and application thereof, and belongs to the technical field of biology. The hybridoma cell strain is named as hybridoma cell strain 2G9A3-35H11, and the preservation number is CCTCC NO: C2015141. The invention takes a conjugate formed by AHD-CP and bovine serum albumin as an antigen to immunize a BALB/c mouse, then spleen cells obtained after immunization are fused with rejuvenated SP2/0 myeloma cells, a culture medium without antibiotic is adopted for cell culture, and hybridoma cell strains are obtained through multiple screening and cloning; the hybridoma cell strain can secrete a large amount of specific antibodies for resisting AHD derivative products during in vitro culture, and can be used for rapid and accurate immunodetection and immunoassay of nitrofurantoin metabolites. |
priorityDate | 2017-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.